Tevogen Inc. (TVGN) SEC filings
TVGN SEC filings moved a median of -1.88% by the close. TVGN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TVGN overview →
72 measured TVGN SEC filing events.
Where these TVGN SEC filings landedvs 72 measured TVGN SEC filing reactions
| Middle 50% of TVGN SEC filing reactions | -4.32% to +1.23% |
|---|---|
| Median reaction (to close) | -1.88% |
| Measured reactions | 72 |
Point-in-time · zero look-ahead
Half of the 72 TVGN SEC filing events with a measured close landed between -4.32% and +1.23%; 32% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Tevogen Inc. For: Sep 29 | SEC filing · Form 8-K | +2.83% | +5.83% | |
| Form 8-K Tevogen Inc. For: Sep 14 | SEC filing · Form 8-K | +3.14% | +8.59% | |
| Form 8-K Tevogen Inc. For: Sep 09 | SEC filing · Form 8-K | — | +0.69% | |
| Form 8-K Tevogen Inc. For: Aug 24 | SEC filing · Form 8-K | — | -1.32% | |
| Form S-8 Tevogen Inc. | SEC filing · Form S-8 | +0.00% | +5.29% | |
| Form 10-Q Tevogen Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.20% | |
| Form DEF 14A Tevogen Inc. For: Aug 03 | SEC filing · Form DEF | +0.00% | -2.90% | |
| Form 8-K Tevogen Bio Holdings For: Jul 29 | SEC filing · Form 8-K | +0.00% | +9.80% | |
| Form PRE 14A Tevogen Bio Holdings For: Jul 23 | SEC filing · Form PRE | +0.00% | +7.16% | |
| Form S-8 Tevogen Bio Holdings | SEC filing · Form S-8 | — | -0.40% | |
| Form EFFECT Tevogen Bio Holdings | SEC filing · Form EFFECT | +3.48% | -26.24% | |
| Form S-3 Tevogen Bio Holdings | SEC filing · Form S-3 | +0.00% | -3.84% | |
| Form 10-Q Tevogen Bio Holdings For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +8.29% | |
| Form 10-K/A Tevogen Bio Holdings For: Dec 31 | SEC filing · Form 10-K | +0.38% | -3.06% | |
| Form 8-K Tevogen Bio Holdings For: Apr 16 | SEC filing · Form 8-K | — | -13.35% | |
| Form 10-K Tevogen Bio Holdings For: Dec 31 | SEC filing · Form 10-K | +2.69% | +0.45% | |
| Form 8-K Tevogen Bio Holdings For: Mar 20 | SEC filing · Form 8-K | +1.52% | -9.33% | |
| Form 8-K Tevogen Bio Holdings For: Mar 03 | SEC filing · Form 8-K | -2.12% | -1.43% | |
| Form 8-K Tevogen Bio Holdings For: Feb 19 | SEC filing · Form 8-K | +0.86% | -0.21% | |
| Form 8-K Tevogen Bio Holdings For: Jan 30 | SEC filing · Form 8-K | -1.54% | -4.32% | |
| Form DEF 14A Tevogen Bio Holdings For: Jan 26 | SEC filing · Form DEF | -0.12% | +2.35% | |
| Form PRE 14A Tevogen Bio Holdings For: Dec 31 | SEC filing · Form PRE | -2.22% | -6.99% | |
| Form 10-Q Tevogen Bio Holdings For: Sep 30 | SEC filing · Form 10-Q | -0.80% | -2.48% | |
| Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q | Press release | +0.45% | -1.95% | |
| Form 8-K Tevogen Bio Holdings For: Sep 23 | SEC filing · Form 8-K | -0.57% | -1.55% | |
| Form 10-Q Tevogen Bio Holdings For: Jun 30 | SEC filing · Form 10-Q | -0.78% | -2.24% | |
| Form 8-K Tevogen Bio Holdings For: Jul 10 | SEC filing · Form 8-K | -1.63% | -0.81% | |
| Form 8-K Tevogen Bio Holdings For: Jul 03 | SEC filing · Form 8-K | +0.83% | -0.83% | |
| Form 8-K Tevogen Bio Holdings For: Jun 30 | SEC filing · Form 8-K | -2.42% | -0.81% | |
| Form EFFECT Tevogen Bio Holdings | SEC filing · Form EFFECT | +0.00% | +5.08% | |
| Form 8-K Tevogen Bio Holdings For: Jun 23 | SEC filing · Form 8-K | +0.86% | +1.72% | |
| Form S-3 Tevogen Bio Holdings | SEC filing · Form S-3 | +1.75% | +1.75% | |
| Form 8-K Tevogen Bio Holdings For: May 30 | SEC filing · Form 8-K | +0.00% | -1.16% | |
| Form 10-Q Tevogen Bio Holdings For: Mar 31 | SEC filing · Form 10-Q | +0.92% | +5.50% | |
| Form EFFECT Tevogen Bio Holdings | SEC filing · Form EFFECT | +0.43% | +6.52% | |
| Form S-8 Tevogen Bio Holdings | SEC filing · Form S-8 | +0.00% | -5.92% | |
| Form DEF 14A Tevogen Bio Holdings For: Apr 30 | SEC filing · Form DEF | +0.00% | -3.13% | |
| Form DEFA14A Tevogen Bio Holdings | SEC filing · Form DEFA14A | +0.00% | -3.13% | |
| Form POS AM Tevogen Bio Holdings | SEC filing · Form POS | +0.00% | -3.13% | |
| Form 8-K Tevogen Bio Holdings For: Apr 21 | SEC filing · Form 8-K | +0.01% | -5.31% | |
| Form DEFA14A Tevogen Bio Holdings | SEC filing · Form DEFA14A | +0.01% | -5.31% | |
| Form 8-K Tevogen Bio Holdings For: Apr 17 | SEC filing · Form 8-K | -1.04% | -2.88% | |
| Form 10-K Tevogen Bio Holdings For: Dec 31 | SEC filing · Form 10-K | -0.47% | -4.76% | |
| Form NT 10-K Tevogen Bio Holdings For: Dec 31 | SEC filing · Form NT | -0.45% | -1.80% | |
| Form 8-K Tevogen Bio Holdings For: Jan 28 | SEC filing · Form 8-K | +4.00% | -3.33% | |
| Form 10-Q Tevogen Bio Holdings For: Sep 30 | SEC filing · Form 10-Q | -3.33% | -13.94% | |
| Form NT 10-Q Tevogen Bio Holdings For: Sep 30 | SEC filing · Form NT | +2.16% | -4.32% | |
| Form 8-K/A Tevogen Bio Holdings For: Aug 20 | SEC filing · Form 8-K | -3.87% | -14.39% | |
| Form 8-K Tevogen Bio Holdings For: Aug 20 | SEC filing · Form 8-K | +1.01% | -10.56% | |
| Form 10-Q Tevogen Bio Holdings For: Jun 30 | SEC filing · Form 10-Q | -0.82% | +0.15% | |
| Tevogen Bio’s Founding CEO, Ryan Saadi, Expresses Conviction in Company’s Growth Strategy and Reaffirms Newly Effective Form S-1 Does Not Relate to Previously Undisclosed New Issuance of Dilutive Securities | Press release | +0.00% | +8.81% | |
| Form EFFECT Tevogen Bio Holdings | SEC filing · Form EFFECT | -1.52% | -7.06% | |
| Form S-1/A Tevogen Bio Holdings | SEC filing · Form S-1 | +0.31% | -4.27% | |
| Form S-1/A Tevogen Bio Holdings | SEC filing · Form S-1 | +0.00% | -3.06% | |
| Form 8-K Tevogen Bio Holdings For: Jun 14 | SEC filing · Form 8-K | -0.74% | -2.04% | |
| Form S-1 Tevogen Bio Holdings | SEC filing · Form S-1 | -0.74% | -2.04% | |
| Form 8-K Tevogen Bio Holdings For: Jun 06 | SEC filing · Form 8-K | -1.21% | +4.82% | |
| Form S-8 Tevogen Bio Holdings | SEC filing · Form S-8 | -2.77% | +0.73% | |
| Form 8-K/A Tevogen Bio Holdings For: Feb 14 | SEC filing · Form 8-K | -2.06% | +3.92% | |
| Form 10-Q Tevogen Bio Holdings For: Mar 31 | SEC filing · Form 10-Q | +0.01% | -0.38% | |
| Form 8-K Tevogen Bio Holdings For: May 10 | SEC filing · Form 8-K | -2.27% | -6.82% | |
| Form NT 10-Q Tevogen Bio Holdings For: Mar 31 | SEC filing · Form NT | -2.27% | -6.82% | |
| Form 8-K Tevogen Bio Holdings For: Apr 29 | SEC filing · Form 8-K | +4.54% | +1.40% | |
| Form 10-K Tevogen Bio Holdings For: Dec 31 | SEC filing · Form 10-K | -3.09% | +2.00% | |
| Form 8-K/A Tevogen Bio Holdings For: Feb 14 | SEC filing · Form 8-K | -3.09% | +2.00% | |
| Form 8-K Tevogen Bio Holdings For: Apr 26 | SEC filing · Form 8-K | -3.33% | -16.67% | |
| Form 8-K/A Tevogen Bio Holdings For: Mar 27 | SEC filing · Form 8-K | -0.41% | +0.00% | |
| Form 8-K Tevogen Bio Holdings For: Mar 27 | SEC filing · Form 8-K | +0.00% | -6.35% | |
| Form NT 10-K Tevogen Bio Holdings For: Dec 31 | SEC filing · Form NT | -1.34% | -12.38% | |
| Form 8-K Tevogen Bio Holdings For: Mar 15 | SEC filing · Form 8-K | — | -3.07% | |
| Form 8-K Tevogen Bio Holdings For: Feb 14 | SEC filing · Form 8-K | -14.49% | +1.18% | |
| Form 8-K/A Tevogen Bio Holdings For: Feb 14 | SEC filing · Form 8-K | +0.00% | -2.44% |
Keep exploring
More TVGN: earnings → · analyst actions → · TVGN overview →